Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
SHPH Stock Price Chart
Explore Shuttle Pharmaceuticals Holdings, Inc. interactive price chart. Choose custom timeframes to analyze SHPH price movements and trends.
SHPH Company Profile
Discover essential business fundamentals and corporate details for Shuttle Pharmaceuticals Holdings, Inc. (SHPH) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
31 Aug 2022
Employees
9.00
Website
https://www.shuttlepharma.comCEO
Christopher Robert Cooper
Description
Shuttle Pharmaceuticals Holdings, Inc., in conjunction with its subsidiary Shuttle Pharmaceuticals, Inc., is committed to the identification, advancement, and commercialization of pharmaceutical agents crafted to heighten the susceptibility of cancerous cells to radiation therapy. Its current portfolio of clinical-phase treatments features Ropidoxuridine, an orally administered halogenated pyrimidine, which is intended for individuals afflicted with brain tumors and soft tissue sarcomas. Additionally, the company is progressing Doranidazole, an injectable compound designed to make oxygen-deprived tumor cells more responsive to radiation, targeting malignancies of the pancreas, lungs, and liver. This enterprise was established in 2012 and maintains its principal operations in Rockville, Maryland.
SHPH Financial Timeline
Browse a chronological timeline of Shuttle Pharmaceuticals Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Stock split effective on 11 Jun 2026
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 May 2026
EPS came in at -$4.30 .
Earnings released on 1 Apr 2026
EPS came in at -$12.90 .
Earnings released on 13 Nov 2025
EPS came in at -$1.05 .
Earnings released on 12 Aug 2025
EPS came in at -$3.29 .
Stock split effective on 16 Jun 2025
Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 8 May 2025
EPS came in at -$7.50 .
Earnings released on 20 Mar 2025
EPS came in at -$0.80 .
Earnings released on 13 Nov 2024
EPS came in at -$39.75 .
Earnings released on 3 Sept 2024
EPS came in at -$24.00 .
Stock split effective on 13 Aug 2024
Shares were split 1 : 8 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 May 2024
EPS came in at -$0.10 .
Earnings released on 21 Mar 2024
EPS came in at -$0.10 .
Earnings released on 13 Nov 2023
EPS came in at -$0.11 .
Earnings released on 14 Aug 2023
EPS came in at -$0.15 .
Earnings released on 25 May 2023
EPS came in at $0.02 .
Earnings released on 15 Mar 2023
EPS came in at -$0.06 .
Earnings released on 14 Nov 2022
EPS came in at -$0.10 .
Earnings released on 30 Jun 2022
EPS came in at -$0.06 .
Earnings released on 31 Mar 2022
EPS came in at -$0.05 .
Earnings released on 31 Dec 2021
EPS came in at -$0.03 .
Earnings released on 30 Sept 2021
EPS came in at -$0.02 .
SHPH Stock Performance
Access detailed SHPH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
